STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06734221
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT06734221
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06734221. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-15 (actual); primary completion 2026-09-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
- Acronym
- STAR-PAK
- Condition
- Popliteal Artery Stenosis Above the Knee
- Condition
- Peripheral Artery Disease
- Condition
- Superficial Femoral Artery Stenosis
- Intervention (Device)
- Paclitaxel Coated Peripheral Angioplasty Balloon Catheter
- Lead sponsor
- Balton Sp.zo.o.
- Collaborator
- KCRI
Record details
- Record id
cardio:ct-nct06734221- Content hash
c885f57aada8b9c2d403fcaad9dc3c326a7e2ca1d54cae866c5e69f621ab894c